News

Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions. Why did you start this company?
BioMEMS Diagnostics, a Michigan-based diagnostics developer, has opened an assay development/optimization laboratory on the Gunnison, Colorado campus of Western ...
PORTLAND, Ore. — Widely considered the father of bioMEMS, Professor Mauro Ferrari has founded a company to commercialize MEMS-based medical solutions and possible space applications. NanoMedical ...
Evidence of this crystallized in the multitude of presentations at the BioMEMS 2002 Conference, which was organized and sponsored by the Knowledge Foundation (www.knowledgefoundation.com).
Bourne Research reports that revenues of BioMEMS (the use of MEMS in biotechnology) alone accounted for nearly $1 billion in 2005. The diversity of BioMEMS devices currently being used is impressive, ...
Scientists are developing implantable biomedical microelectromechanical systems (bioMEMS) that can monitor your blood chemistry in real time, deliver timed and quantized doses of medication ...
BioMEMS devices, defined as MEMS sensors and microfluidic devices integrated into medical devices and used for IVD and life sciences, were a $3.7 billion Market in 2019 and is expected to reach $6.3 ...
In addition, we will cover topics in BioMEMS technology as it relates to cell investigations. The class will combine instructor lectures, based on relevant books and papers from high-impact journals, ...